Table 1: The general characteristics of all the 80 patients.
| Control | Treated | |
| N (M/F) | 36 (15/21) | 38 (16/22) |
| Age (Year) | 35.5 ± 6.0 | 36.2 ± 6.6 |
| Height (cm) | 172.1 ± 5.2 | 170.6 ± 5.5 |
| Weight (kg) | 84.6 ± 7.2 | 83.7 ± 7.5 |
| BMI (kg/m2) | 28.5 ± 1.7 | 28.7 ± 1.6 |
| WC (cm) | 90.3 ± 3.6 | 90.3 ± 4.0 |
| HC (cm) | 99.8 ± 3.3 | 99.1 ± 3.6 |
| WHR (%) | 0.91 ± 0.04 | 0.91 ± 0.05 |
| HbA1c (%) | 7.35 ± 0.89 | 7.28 ± 1.02 |
| FPG (mmol/L) | 7.69 ± 1.03 | 7.76 ± 0.97 |
| 2hPG (mmol/L) | 12.02 ± 1.77 | 11.81 ± 2.07 |
| FINS (μIU/mL) | 19.10 ± 7.36 | 19.24 ± 8.82 |
| HOMA-IR | 6.53 ± 2.61 | 6.64 ± 3.19 |
| TG (mmol/L) | 2.46 ± 0.98 | 2.52 ± 1.00 |
| TC (mmol/L) | 5.38 ± 1.08 | 5.28 ± 0.97 |
| HDL (mmol/L) | 1.35 ± 0.30 | 1.32 ± 0.27 |
| LDL (mmol/L) | 3.22 ± 0.93 | 3.30 ± 0.87 |
| FFA (mmol/L) | 0.69 ± 0.14 | 0.68 ± 0.16 |
BMI: Body Mass Index; WC: Waist Circumference; HC: Hip Circumference; WHR: Waist-To-Hip Ratio; HbA1c: Glycosylated Hemoglobin; FPG: Fasting Plasma Glucose; 2hPG: 2h Post-Prandial Plasma Glucose; FINS: Fasting Insulin; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance; TG: Triglyceride; TC: Total Cholesterol; HDL: High Density Lipoprotein Cholesterol; LDL: Low Density Lipoprotein Cholesterol; FFA: Free Fatty Acids